Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders

Jacques A.J. Malherbe, Jeanie Misko, Nishani K. Jayawardena, Matthew D.M. Rawlins, Laurens Manning, Duncan Purtill

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science